Form 25-NSE ANTARES PHARMA, INC. Filed by: Nasdaq Stock Market LLC

    X0203

    
        0001354457
        Nasdaq Stock Market LLC
    

    
        0001016169
        ANTARES PHARMA, INC.
        001-32302
        

            100 Princeton South
            Suite 300
            Ewing
            NJ
            NEW JERSEY
            08626
        
        1 609 359 3016
    

    Common Stock

    17 CFR 240.12d2-2(a)(3)

    
        O'Neil Blake
        Senior Specialist
        2022-05-24
    

atrs-form25

You May Also Be Interested In

• Canadian Pacific Kansas City Limited declares dividend
• An adventure every day after school: Boys and Girls Clubs of Central Arizona
• ADASTRA HOLDINGS REPORTS FY2023 RESULTS; MARKING THIRD CONSECUTIVE YEAROF RECORD REVENUE